{"title": "Salvia divinorum: un estudio fenomenol\u00f3gico y cognitivo de la experiencia en usuarios de Latinoam\u00e9rica y Espa\u00f1a.", "author": "Laura Nava-G\u00f3mez; Juan Carlos Gonz\u00e1lez-Gonz\u00e1lez", "url": null, "hostname": null, "description": "La planta Salvia divinorum (Ska pastora, Hierba Mar\u00eda, Mar\u00eda Pastora), es una planta end\u00e9mica mexicana de la familia de las mentas, con larga historia de uso tradicional entre nativos de la Sierra de Oaxaca, en M\u00e9xico. Se emplea en pr\u00e1cticas religiosas, curativas y adivinatorias, y es uno de los componentes principales de ceremonias de sanaci\u00f3n f\u00edsica y espiritual, siendo beneficiosa tanto para tratar afecciones gastrointestinales como para tratar el alcoholismo, entre otras. En ambientes urbanos industrializados de Latinoam\u00e9rica y Espa\u00f1a, su uso recreativo se ha extendido y sus efectos subjetivos est\u00e1n todav\u00eda poco documentados en la literatura cient\u00edfica con validez ecol\u00f3gica, lo que limita el conocimiento sobre sus efectos en ambientes poco controlados. Comprender el uso no-tradicional contempor\u00e1neo es deseable (y quiz\u00e1s necesario) para evitar los consumos problem\u00e1ticos y explorar potenciales usos ben\u00e9ficos \u2014ya sean terap\u00e9uticos, cl\u00ednicos o cognitivos\u2014 sobre todo de cara a la inminente legalizaci\u00f3n de las sustancias psicod\u00e9licas en muchos pa\u00edses del mundo. Este estudio se enfoca principalmente en el aspecto subjetivo de la experiencia con Salvia divinorum y en su interpretaci\u00f3n post-facto, analizando la percepci\u00f3n y otros procesos cognitivos y emocionales propios de la experiencia en usuarios contempor\u00e1neos. Se concluye que un uso planificado de la Salvia divinorum podr\u00eda tener efectos positivos en t\u00e9rminos terap\u00e9uticos y como potenciador cognitivo. Sin embargo, es necesario profundizar la investigaci\u00f3n e incluir m\u00e9todos cuantitativos de las ciencias cognitivas para integrar un conocimiento s\u00f3lido de su psicofarmacolog\u00eda y neurofenomenolog\u00eda.", "sitename": "Revista ConCiencia EPG", "date": "2022-04-09", "id": null, "license": "CC BY-NC 4.0", "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Salvia divinorum: un estudio fenomenol\u00f3gico y cognitivo de la experiencia en usuarios de Latinoam\u00e9rica y Espa\u00f1a.\nDOI:\n[https://doi.org/10.32654/ConCienciaEPG/Eds.especial-9](https://doi.org/10.32654/ConCienciaEPG/Eds.especial-9)\nPalabras clave:#Salvia divinorum, #salvinorina A, #Fenomenolog\u00eda, #Potenciadores Cognitivos, #Estados Modificados de Conciencia, #Psicod\u00e9licos, #Ciencias Cognitivas\nResumen\nLa planta Salvia divinorum (Ska pastora, Hierba Mar\u00eda, Mar\u00eda Pastora), es una planta end\u00e9mica mexicana de la familia de las mentas, con larga historia de uso tradicional entre nativos de la Sierra de Oaxaca, en M\u00e9xico. Se emplea en pr\u00e1cticas religiosas, curativas y adivinatorias, y es uno de los componentes principales de ceremonias de sanaci\u00f3n f\u00edsica y espiritual, siendo beneficiosa tanto para tratar afecciones gastrointestinales como para tratar el alcoholismo, entre otras. En ambientes urbanos industrializados de Latinoam\u00e9rica y Espa\u00f1a, su uso recreativo se ha extendido y sus efectos subjetivos est\u00e1n todav\u00eda poco documentados en la literatura cient\u00edfica con validez ecol\u00f3gica, lo que limita el conocimiento sobre sus efectos en ambientes poco controlados. Comprender el uso no-tradicional contempor\u00e1neo es deseable (y quiz\u00e1s necesario) para evitar los consumos problem\u00e1ticos y explorar potenciales usos ben\u00e9ficos \u2014ya sean terap\u00e9uticos, cl\u00ednicos o cognitivos\u2014 sobre todo de cara a la inminente legalizaci\u00f3n de las sustancias psicod\u00e9licas en muchos pa\u00edses del mundo. Este estudio se enfoca principalmente en el aspecto subjetivo de la experiencia con Salvia divinorum y en su interpretaci\u00f3n post-facto, analizando la percepci\u00f3n y otros procesos cognitivos y emocionales propios de la experiencia en usuarios contempor\u00e1neos. Se concluye que un uso planificado de la Salvia divinorum podr\u00eda tener efectos positivos en t\u00e9rminos terap\u00e9uticos y como potenciador cognitivo. Sin embargo, es necesario profundizar la investigaci\u00f3n e incluir m\u00e9todos cuantitativos de las ciencias cognitivas para integrar un conocimiento s\u00f3lido de su psicofarmacolog\u00eda y neurofenomenolog\u00eda.\nDescargas\nM\u00e9tricas\nCitas\nAddy, P. H. (2012). Acute and post-acute behavioral and psychological effects of salvinorin A in humans. Psychopharmacology, 220(1), 195\u2013204.\n[https://doi.org/10.1007/S00213-011-2470-6](https://doi.org/10.1007/S00213-011-2470-6)\nAddy, P. H., Garcia-Romeu, A., Metzger, M., & Wade, J. (2015). The subjective experience of acute, experimentally-induced Salvia divinorum inebriation. Journal of Psychopharmacology, 29(4), 426\u2013435.\n[https://doi.org/10.1177/0269881115570081](https://doi.org/10.1177/0269881115570081)\nAnderson, R. I., Lopez, M. F., Griffin, W. C., Haun, H. L., Bloodgood, D. W., Pati, D., Boyt, K. M., Kash, T. L., & Becker, H. C. (2019). Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 44(6), 1084\u20131092.\n[https://doi.org/10.1038/S41386-018-0294-3](https://doi.org/10.1038/S41386-018-0294-3)\nBaggott, M. J., Erowid, E., Erowid, F., Galloway, G. P., & Mendelson, J. (2010). Use patterns and self-reported effects of Salvia divinorum: An internet-based survey. Drug and Alcohol Dependence, 111(3), 250\u2013256.\n[https://doi.org/10.1016/j.drugalcdep.2010.05.003](https://doi.org/10.1016/j.drugalcdep.2010.05.003)\nBarrett, F. S., Bradstreet, M. P., Leoutsakos, J. M. S., Johnson, M. W., & Griffiths, R. R. (2016). The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology, 30(12), 1279\u20131295.\n[https://doi.org/10.1177/0269881116678781](https://doi.org/10.1177/0269881116678781)\nBerg\u00e9, D., Bulbena, A., Sperry, L., Pailhez, G., Valls, S., Mart\u00edn-Santos, R., & Berrios, G. (2009). S\u00edntomas de despersonalizaci\u00f3n en pacientes psiqui\u00e1tricos: La nueva escala de despersonalizaci\u00f3n presente-vida (DP-PV). Archivos de Psiquiatria, 72(1\u20134), 1\u201313.\nBienemann, B., Ruschel, N. S., Campos, M. L., Negreiros, M. A., & Mograbi, D. C. (2020). Self-reported negative outcomes of psilocybin users: A quantitative textual analysis. PLoS ONE, 15(2), 1\u201314.\n[https://doi.org/10.1371/journal.pone.0229067](https://doi.org/10.1371/journal.pone.0229067)\nBraida, D., Capurro, V., Zani, A., Rubino, T., Vigan\u00f2, D., Parolaro, D., & Sala, M. (2009). Potential anxiolytic- And antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. British Journal of Pharmacology, 157(5), 844\u2013853.\n[https://doi.org/10.1111/j.1476-5381.2009.00230.x](https://doi.org/10.1111/j.1476-5381.2009.00230.x)\nButelman, E. R., & Kreek, M. J. (2015). Salvinorin A, a kappa-opioid receptor agonist hallucinogen: Pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders. Frontiers in Pharmacology, 6(SEP), 1\u20137.\n[https://doi.org/10.3389/fphar.2015.00190](https://doi.org/10.3389/fphar.2015.00190)\nButelman, E. R., Mandau, M., Tidgewell, K., Prisinzano, T. E., Yuferov, V., & Kreek, M. J. (2007). Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans. The Journal of Pharmacology and Experimental Therapeutics, 320(1), 300\u2013306.\n[https://doi.org/10.1124/jpet.106.112417](https://doi.org/10.1124/jpet.106.112417)\nButelman, E. R., Prisinzano, T. E., Deng, H., Rus, S., & Kreek, M. J. (2009). Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: Fast onset and entry into cerebrospinal fluid. The Journal of Pharmacology and Experimental Therapeutics, 328(2), 588\u2013597.\n[https://doi.org/10.1124/jpet.108.145342](https://doi.org/10.1124/jpet.108.145342)\nCanal, C., & Murnane, K. (2016). The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens. Journal Of Psychopharmacology, 31(1), 127-143. doi: 10.1177/0269881116677104\nCarhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., Hobden, P., Evans, J., Feilding, A., Wise, R. G., & Nutt, D. J. (2012). Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proceedings of the National Academy of Sciences, 109(6), 2138\u20132143.\n[https://doi.org/10.1073/pnas.1119598109](https://doi.org/10.1073/pnas.1119598109)\nCarhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., Leech, R., Curran, H. V., & Nutt, D. J. (2017). Psilocybin for treatment-resistant depression: FMRI-measured brain mechanisms. Scientific Reports, 7(1), 1\u201311.\n[https://doi.org/10.1038/s41598-017-13282-7](https://doi.org/10.1038/s41598-017-13282-7)\nCarhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018). Psychedelics and the essential importance of context. Journal of Psychopharmacology, 32(7), 725\u2013731.\n[https://doi.org/10.1177/0269881118754710](https://doi.org/10.1177/0269881118754710)\nCarhart-Harris, R. L., Wall, M. B., Erritzoe, D., Kaelen, M., Ferguson, B., De Meer, I., Tanner, M., Bloomfield, M., Williams, T. M., Bolstridge, M., Stewart, L., Morgan, C. J., Newbould, R. D., Feilding, A., Curran, H. V., & Nutt, D. J. (2014). The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories. The International Journal of Neuropsychopharmacology, 17(04), 527\u2013540.\n[https://doi.org/10.1017/S1461145713001405](https://doi.org/10.1017/S1461145713001405)\nCastner, S., & Goldman-Rakic, P. (2003). Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates. Biological Psychiatry, 54(2), 105-110. doi: 10.1016/s0006-3223(03)00292-0\nChernik, D., Gillings, D., Laine, H., Hendler, J., Silver, J., & Davidson, A. et al. (1990). Validity and Reliability of the Observer??s. Journal of Clinical Psychopharmacology, 10(4), 244???251. doi: 10.1097/00004714-199008000-00003\nClark, S., & Abi-Dargham, A. (2019). The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence. Biological Psychiatry, 86(7), 502-511. doi: 10.1016/j.biopsych.2019.05.012\nCole S, Richardson R, McNally GP (2013) Ventral Hippocampal Kappa Opioid Receptors Mediate the Renewal of Fear following Extinction in the Rat. PLoS ONE 8(5): e58701.\n[https://doi.org/10.1371/journal.pone.0058701](https://doi.org/10.1371/journal.pone.0058701)\nColeman, B. C., Manz, K. M., & Grueter, B. A. (2021). Kappa opioid receptor modulation of excitatory drive onto nucleus accumbens fast-spiking interneurons. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 46(13), 2340\u20132349.\n[https://doi.org/10.1038/S41386-021-01146-8](https://doi.org/10.1038/S41386-021-01146-8)\nCunningham, C. W., Rothman, R. B., & Prisinzano, T. E. (2011). Neuropharmacology of the naturally occurring \u03ba-opioid hallucinogen salvinorin A. Pharmacological Reviews, 63(2), 316\u2013347.\n[https://doi.org/10.1124/pr.110.003244](https://doi.org/10.1124/pr.110.003244)\nCurrie, C. L. (2013). Epidemiology of adolescent Salvia divinorum use in Canada. Drug and Alcohol Dependence, 128(1\u20132), 166\u2013170.\n[https://doi.org/10.1016/j.drugalcdep.2012.08.008](https://doi.org/10.1016/j.drugalcdep.2012.08.008)\nDe Gregorio, D., Comai, S., Posa, L., & Gobbi, G. (2016). D-Lysergic Acid Diethylamide (LSD) as a model of psychosis: Mechanism of action and pharmacology. In International Journal of Molecular Sciences (Vol. 17, Issue 11). MDPI AG.\n[https://doi.org/10.3390/ijms17111953](https://doi.org/10.3390/ijms17111953)\nDEA. (2021). Drug Scheduling. Drug Scheduling.\n[https://www.dea.gov/drug-information/drug-scheduling](https://www.dea.gov/drug-information/drug-scheduling)\nD\u00edaz, J. L. (1977). Ethnopharmacology of sacred psychoactive plants used by the Indians of Mexico. Annual Review of Pharmacology and Toxicology, 17, 647\u2013675.\n[https://doi.org/10.1146/ANNUREV.PA.17.040177.003243](https://doi.org/10.1146/ANNUREV.PA.17.040177.003243)\nD\u00edaz, J. L. (2013). Salvia divinorum: a psychopharmacological riddle and a mind-body prospect. Current Drug Abuse Reviews, 6(1), 43\u201353.\n[https://doi.org/CDAR-EPUB-20130429-4](https://doi.org/CDAR-EPUB-20130429-4) [pii]\nD\u00edaz, J. L., & Flores, E. O. (2001). La estructura de la emoci\u00f3n humana: Un modelo crom\u00e1tico del sistema afectivo. Salud Mental, 24(4), 20\u201335.\nDir\u017eyt\u0117, A., Ka\u010derauskas, T., & Perminas, A. (2021). Associations between happiness, attitudes towards creativity and self-reported creativity in Lithuanian youth sample. Thinking Skills and Creativity, 40, 100826.\n[https://doi.org/10.1016/j.tsc.2021.100826](https://doi.org/10.1016/j.tsc.2021.100826)\nDong, H. P., Zhou, W., Ma, X. X., He, Z. Z., & Wang, Z. H. (2018). Salvinorin a preserves cerebral pial artery autoregulation after forebrain ischemia via the PI3K/AKT/cGMP pathway. Brazilian Journal of Medical and Biological Research, 51(5).\n[https://doi.org/10.1590/1414-431x20176714](https://doi.org/10.1590/1414-431x20176714)\nDong, H., Zhou, W., Xin, J., Shi, H., Yao, X., He, Z., & Wang, Z. (2019). Salvinorin A moderates postischemic brain injury by preserving endothelial mitochondrial function via AMPK/Mfn2 activation. Experimental Neurology, 322.\n[https://doi.org/10.1016/j.expneurol.2019.113045](https://doi.org/10.1016/j.expneurol.2019.113045)\nDuque, H., & Aristiz\u00e1bal D\u00edaz-Granados, E. (2019). An\u00e1lisis fenomenol\u00f3gico interpretativo. Una gu\u00eda metodol\u00f3gica para su uso en la investigaci\u00f3n cualitativa en psicolog\u00eda. Pensando Psicolog\u00eda, 15(25), 1\u201324.\nDykstra, L. A., Bertalmio, A. J., & Woods, J. H. (1988). Discriminative and analgesic effects of mu and kappa opioids: in vivo pA2 analysis. Psychopharmacology Series, 4, 107\u2013121.\n[https://doi.org/10.1007/978-3-642-73223-2_9](https://doi.org/10.1007/978-3-642-73223-2_9)\nEpling, C., & Jativa, C. D. (1962). A new species of salvia from Mexico. Botanical Museum Leaflets 20: 75. Harvard University.\nEuropean Centre for Drugs and Drug Addiction (2022) Salvia divinorum drug profile. Disponible en\n[https://www.emcdda.europa.eu/publications/drug-profiles/salvia_en](https://www.emcdda.europa.eu/publications/drug-profiles/salvia_en)\nFerrari, R., le Nov\u00e8re, N., Picciotto, M. R., Changeux, J. P., & Zoli, M. (2002). Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. European Journal of Neuroscience, 15(11), 1810\u20131818.\n[https://doi.org/10.1046/j.1460-9568.2001.02009.x](https://doi.org/10.1046/j.1460-9568.2001.02009.x)\nFichna J, Schicho R, Andrews CN, et al. Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors. Neurogastroenterol Motil. 2009;21(12):1326\u2013e128.\nFortier-Davy, M., & Milli\u00e8re, R. (2020). The multi-dimensional approach to drug-induced states: A commentary on Bayne and Carter\u2019s \u201cdimensions of consciousness and the psychedelic state.\u201d Neuroscience of Consciousness, 2020(1), 1DUMM.\n[https://doi.org/10.1093/NC/NIAA004](https://doi.org/10.1093/NC/NIAA004)\nGarc\u00eda Cerqueda, O. (2014) Huautla: Tierra de magia, de hongos... y hippies, 1960-1975. Benem\u00e9rita Universidad Aut\u00f3noma de Puebla. ISBN 6074876770, 9786074876772\nGashi, L., Sandberg, S., & Pedersen, W. (2021). Making \u201cbad trips\u201d good: How users of psychedelics narratively transform challenging trips into valuable experiences. International Journal of Drug Policy, 87, 102997. doi: 10.1016/j.drugpo.2020.102997\nG\u00f3mez-Pompa, A. (1957). Salvia divinorum Epling & J\u00e1tiva. Departamento de Bot\u00e1nica, Instituto de Biolog\u00eda (IBUNAM), Salvia divinorum Epling & J\u00e1tiva, ejemplar de: Herbario Nacional de M\u00e9xico (MEXU), Plantas Vasculares. En Portal de Datos Abiertos UNAM (en l\u00ednea), M\u00e9xico, Universidad Nacional Aut\u00f3noma de M\u00e9xico. Disponible en:\n[http://datosabiertos.unam.mx/IBUNAM:MEXU:87556](http://datosabiertos.unam.mx/IBUNAM:MEXU:87556)\nGonz\u00e1lez, D., Riba, J., Bouso, J. C., G\u00f3mez-Jarabo, G., & Barbanoj, M. J. (2006). Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug and Alcohol Dependence, 85(2), 157\u2013162.\n[https://doi.org/10.1016/j.drugalcdep.2006.04.001](https://doi.org/10.1016/j.drugalcdep.2006.04.001)\nGonz\u00e1lez, J. C. (2017). La d\u00e9r\u00e9alisation pharmacog\u00e9nique en tant qu\u2019EMC paradigmatique. Intellectica. Revue de l\u2019Association Pour La Recherche Cognitive, 67(1), 81\u201394.\n[https://doi.org/10.3406/intel.2017.1836](https://doi.org/10.3406/intel.2017.1836)\nGorman, I., Nielson, E. M., Molinar, A., Cassidy, K., & Sabbagh, J. (2021). Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice. Frontiers in Psychology, 12, 710.\n[https://doi.org/10.3389/FPSYG.2021.645246/BIBTEX](https://doi.org/10.3389/FPSYG.2021.645246/BIBTEX)\nGrilli, M., Neri, E., Zappettini, S., Massa, F., Bisio, A., & Romussi, G. et al. (2009). Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals. Neuropharmacology, 57(5-6), 523-530. doi: 10.1016/j.neuropharm.2009.07.023\nGrof, S. (1980). LSD psychotherapy. Hunter House.\nGrob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstad, A. L., & Greer, G. R. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry, 68(1), 71\u201378.\n[https://doi.org/10.1001/archgenpsychiatry.2010.116](https://doi.org/10.1001/archgenpsychiatry.2010.116)\nGrundmann, O., Phipps, S. M., Zadezensky, I., & Butterweck, V. (2007). Salvia divinorum and salvinorin A: An update on pharmacology and analytical methodology. Planta Medica, 73(10), 1039\u20131046.\n[https://doi.org/10.1055/s-2007-981566](https://doi.org/10.1055/s-2007-981566)\nHanes, K. R. (2001). Antidepressant effects of the herb salvia divinorum: A case report [12]. In Journal of Clinical Psychopharmacology (Vol. 21, Issue 6, pp. 634\u2013635). J Clin Psychopharmacol.\n[https://doi.org/10.1097/00004714-200112000-00025](https://doi.org/10.1097/00004714-200112000-00025)\nHanna, J. (1999). Growing Salvia divinorum from seed. The Entheogen Review, VIII (3), 110\u2013124.\nHarden, M. T., Smith, S. E., Niehoff, J. A., McCurdy, C. R., & Taylor, G. T. (2012). Antidepressive effects of the \u03ba-opioid receptor agonist salvinorin A in a rat model of anhedonia. Behavioural Pharmacology, 23(7), 710\u2013715.\n[https://doi.org/10.1097/FBP.0b013e3283586189](https://doi.org/10.1097/FBP.0b013e3283586189)\nHern\u00e1ndez-Bello, R., Garc\u00eda-Rodr\u00edguez, R. V., Garc\u00eda-Sosa, K., Pe\u00f1a-Rodr\u00edguez, L. M., V\u00e1zquez-Hern\u00e1ndez, M., Ramos-Morales, F. R., Corcoran, O., & S\u00e1nchez-Medina, A. (2015). Salvinorin A content in legal high products of Salvia divinorum sold in Mexico. Forensic Science International, 249, 197\u2013201.\n[https://doi.org/10.1016/j.forsciint.2015.01.038](https://doi.org/10.1016/j.forsciint.2015.01.038)\nHofmann, A. (1978). Historical view on ergot alkaloids. Pharmacology, 16(Suppl. 1), 1\u201311.\n[https://doi.org/10.1159/000136803](https://doi.org/10.1159/000136803)\nHofmann, A. (1979). LSD, mein Sorgenkind. 231.\nHofmann, A. (1980). LSD: Como descubr\u00ed el \u00e1cido y que paso despu\u00e9s en el mundo. Editorial GEDISA. ISBN: 978-84-9784-172-6\nHofmann, A., Frey, A., Ott, H., Petrzilka, T., & Troxler, F. (1958). Konstitutionsaufkl\u00e4rung und Synthese von Psilocybin. Experientia, 14(11), 397\u2013399.\n[https://doi.org/10.1007/BF02160424](https://doi.org/10.1007/BF02160424)\nHofmann, A., Heim, R., Brack, A., Kobel, H., Frey, A., Ott, H., Petrzilka, T., & Troxler, F. (1959). Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen. Helvetica Chimica Acta, 42(5), 1557\u20131572.\n[https://doi.org/10.1002/hlca.19590420518](https://doi.org/10.1002/hlca.19590420518)\nHood, R. W. (1975). The Construction and Preliminary Validation of a Measure of Reported Mystical Experience. Journal for the Scientific Study of Religion, 14(1), 29.\n[https://doi.org/10.2307/1384454](https://doi.org/10.2307/1384454)\nHooker, J. M., Xu, Y., Schiffer, W., Shea, C., Carter, P., & Fowler, J. S. (2008). Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans. NeuroImage, 41(3), 1044\u20131050.\n[https://doi.org/10.1016/j.neuroimage.2008.03.003](https://doi.org/10.1016/j.neuroimage.2008.03.003)\nHuxley, A., Palmer, C., and Horowitz, M. (1977). Moksha: Writings on Psychedelics and the Visionary Experience (1931-1963). New York, NY: Stonehill.\nInstituto Nacional de salud p\u00fablica (2022). Alcoholismo, una relaci\u00f3n t\u00f3xica. Disponible en\n[https://www.insp.mx/avisos/5128-dia-uso-nocivo-alcohol.html](https://www.insp.mx/avisos/5128-dia-uso-nocivo-alcohol.html)\nJermain, J. D., & Evans, H. K. (2009). Analyzing salvia divinorum and its active ingredient salvinorin a utilizing thin layer chromatography and gas chromatography/mass spectrometry. Journal of Forensic Sciences, 54(3), 612\u2013616.\n[https://doi.org/10.1111/j.1556-4029.2009.00999.x](https://doi.org/10.1111/j.1556-4029.2009.00999.x)\nJi, G., & Neugebauer, V. (2020). Kappa opioid receptors in the central amygdala modulate spinal nociceptive processing through an action on amygdala CRF neurons. Molecular Brain, 13(1), 1\u201310.\n[https://doi.org/10.1186/S13041-020-00669-3/FIGURES/3](https://doi.org/10.1186/S13041-020-00669-3/FIGURES/3)\nJohansen, P. \u00d8., & Krebs, T. S. (2015). Psychedelics not linked to mental health problems or suicidal behavior: a population study. Journal of psychopharmacology (Oxford, England), 29(3), 270\u2013279.\n[https://doi.org/10.1177/0269881114568039](https://doi.org/10.1177/0269881114568039)\nJohnson, M. W., MacLean, K. A., Reissig, C. J., Prisinzano, T. E., & Griffiths, R. R. (2011). Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum. Drug and Alcohol Dependence, 115(1\u20132), 150\u2013155.\n[https://doi.org/10.1016/j.drugalcdep.2010.11.005](https://doi.org/10.1016/j.drugalcdep.2010.11.005)\nJohnson, M. W., Richards, W. A., & Griffiths, R. R. (2008). Human hallucinogen research: Guidelines for safety. In Journal of Psychopharmacology (Vol. 22, Issue 6, pp. 603\u2013620). J Psychopharmacol.\n[https://doi.org/10.1177/0269881108093587](https://doi.org/10.1177/0269881108093587)\nKarkhanis, A., Holleran, K. M., & Jones, S. R. (2017). Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction. International Review of Neurobiology, 136, 53\u201388.\n[https://doi.org/10.1016/BS.IRN.2017.08.001](https://doi.org/10.1016/BS.IRN.2017.08.001)\nKivell, B., Uzelac, Z., Sundaramurthy, S., Rajamanickam, J., Ewald, A., Chefer, V., Jaligam, V., Bolan, E., Simonson, B., Annamalai, B., Mannangatti, P., Prisinzano, T. E., Gomes, I., Devi, L. A., Jayanthi, L. D., Sitte, H. H., Ramamoorthy, S., & Shippenberg, T. S. (2014). Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology, 86, 228\u2013240.\n[https://doi.org/10.1016/j.neuropharm.2014.07.016](https://doi.org/10.1016/j.neuropharm.2014.07.016)\nKnoll, A. T., & Carlezon, W. A. (2010). Dynorphin, stress, and depression. Brain Research, 1314C, 56.\n[https://doi.org/10.1016/J.BRAINRES.2009.09.074](https://doi.org/10.1016/J.BRAINRES.2009.09.074)\nLange, J. E., Daniel, J., Homer, K., Reed, M. B., & Clapp, J. D. (2010). Salvia divinorum: Effects and use among YouTube users. Drug and Alcohol Dependence, 108(1\u20132), 138\u2013140.\n[https://doi.org/10.1016/j.drugalcdep.2009.11.010](https://doi.org/10.1016/j.drugalcdep.2009.11.010)\nLee, M. A., & Shlain, B. (1985). Acid dreams: The complete social history of LSD: the CIA, the sixties, and beyond. New York: Grove Press.\nLemaire, S., Lafrance, L., & Dumont, M. (1986). Synthesis and biological activity of dynorphin-(1-13) and analogs substituted in positions 8 and 10. International Journal of Peptide and Protein Research, 27(3), 300\u2013305.\n[https://doi.org/10.1111/J.1399-3011.1986.TB01824.X](https://doi.org/10.1111/J.1399-3011.1986.TB01824.X)\nMacDougal, J. (1997) Salvia divinorum Epling & J\u00e1tiva. Departamento de Bot\u00e1nica, Instituto de Biolog\u00eda (IBUNAM), Salvia divinorum Epling & J\u00e1tiva, ejemplar de: Herbario Nacional de M\u00e9xico (MEXU), Plantas Vasculares. En Portal de Datos Abiertos UNAM (en l\u00ednea), M\u00e9xico, Universidad Nacional Aut\u00f3noma de M\u00e9xico. Disponible en\n[http://datosabiertos.unam.mx/IBUNAM:MEXU:1051410](http://datosabiertos.unam.mx/IBUNAM:MEXU:1051410)\nMacLean, K. A., Johnson, M. W., Reissig, C. J., Prisinzano, T. E., & Griffiths, R. R. (2013). Dose-related effects of salvinorin A in humans: Dissociative, hallucinogenic, and memory effects. Psychopharmacology, 226(2), 381\u2013392.\n[https://doi.org/10.1007/s00213-012-2912-9](https://doi.org/10.1007/s00213-012-2912-9)\nManske, R. H. F. (1931). A synthesis of the methyltryptamines and some derivatives. Canadian Journal of Research, 5(5), 592\u2013600.\n[https://doi.org/10.1139/cjr31-097](https://doi.org/10.1139/cjr31-097)\nMaqueda, A. E., Valle, M., Addy, P. H., Antonijoan, R. M., Puntes, M., Coimbra, J., Ballester, M. R., Garrido, M., Gonz\u00e1lez, M., Claramunt, J., Barker, S., Lomnicka, I., Waguespack, M., Johnson, M. W., Griffiths, R. R., & Riba, J. (2016). Naltrexone but not ketanserin antagonizes the subjective, cardiovascular, and neuroendocrine effects of salvinorin-A in humans. International Journal of Neuropsychopharmacology, 19, 1\u201313.\n[https://doi.org/10.1093/ijnp/pyw016](https://doi.org/10.1093/ijnp/pyw016)\nMatthew, H. (1968). Lysergic Acid Diethylamide Intoxication. British Medical Journal, 1(5588), 380.\n[https://doi.org/10.1136/bmj.1.5588.380](https://doi.org/10.1136/bmj.1.5588.380)\nMcCurdy, C., Sufka, K., Smith, G., Warnick, J., & Nieto, M. (2006). Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist. Pharmacology Biochemistry and Behavior, 83(1), 109-113. doi: 10.1016/j.pbb.2005.12.011\nMedana, C., Massolino, C., Pazzi, M. and Baiocchi, C. (2006), Determination of salvinorins and divinatorins in Salvia divinorum leaves by liquid chromatography/multistage mass spectrometry. Rapid Commun. Mass Spectrom., 20: 131-136.\n[https://doi.org/10.1002/rcm.2288](https://doi.org/10.1002/rcm.2288)\nMendrek, A. (2014). Existe-t-il des diff\u00e9rences entre les hommes et les femmes en ce qui concerne les probl\u00e8mes de toxicomanie? Sant\u00e9 Mentale Au Qu\u00e9bec, 39(2), 57\u201374.\n[https://doi.org/10.7202/1027832AR](https://doi.org/10.7202/1027832AR)\nMiller, J. M., Zanderigo, F., Purushothaman, P. D., DeLorenzo, C., Rubin-Falcone, H., Ogden, R. T., Keilp, J., Oquendo, M. A., Nabulsi, N., Huang, Y. H., Parsey, R. V., Carson, R. E., & Mann, J. J. (2018). Kappa opioid receptor binding in major depression: A pilot study. Synapse (New York, N.Y.), 72(9), e22042.\n[https://doi.org/10.1002/syn.22042](https://doi.org/10.1002/syn.22042)\nMithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of \u00b13,4-methylenedioxymethamphetamine- assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology, 25(4), 439\u2013452.\n[https://doi.org/10.1177/0269881110378371](https://doi.org/10.1177/0269881110378371)\nMorani, A. S., Kivell, B., Prisinzano, T. E., & Schenk, S. (2009). Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats. Pharmacology Biochemistry and Behavior, 94(2), 244\u2013249.\n[https://doi.org/10.1016/j.pbb.2009.09.002](https://doi.org/10.1016/j.pbb.2009.09.002)\nMores, K. L., Cummins, B. R., Cassell, R. J., & van Rijn, R. M. (2019). A review of the therapeutic potential of recently developed G protein-biased kappa agonists. Frontiers in Pharmacology, 10(APR), 407.\n[https://doi.org/10.3389/FPHAR.2019.00407/BIBTEX](https://doi.org/10.3389/FPHAR.2019.00407/BIBTEX)\nMuncan, B., Walters, S. M., Ezell, J., & Ompad, D. C. (2020). \u201cthey look at us like junkies\u201d: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduction Journal, 17(1), 1\u20139.\n[https://doi.org/10.1186/S12954-020-00399-8/TABLES/2](https://doi.org/10.1186/S12954-020-00399-8/TABLES/2)\nMunro, T. A., & Rizzacasa, M. A. (2003). Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A. Journal of Natural Products, 66(5), 703\u2013705.\n[https://doi.org/10.1021/np0205699](https://doi.org/10.1021/np0205699)\nNapoletano, F., Schifano, F., Corkery, J. M., Guirguis, A., Arillotta, D., Zangani, C., & Vento, A. (2020). The Psychonauts\u2019 World of Cognitive Enhancers. Frontiers in Psychiatry, 11, 908.\n[https://doi.org/10.3389/FPSYT.2020.546796/BIBTEX](https://doi.org/10.3389/FPSYT.2020.546796/BIBTEX)\nNava-G\u00f3mez, L., Fuentes-Castillo, P. (2015). Salvia divinorum Epling & J\u00e1tiva. Departamento de Bot\u00e1nica, Instituto de Biolog\u00eda (IBUNAM), Salvia divinorum Epling & J\u00e1tiva, ejemplar de: Herbario Nacional de M\u00e9xico (MEXU), Plantas Vasculares. En Portal de Datos Abiertos UNAM (en l\u00ednea), M\u00e9xico, Universidad Nacional Aut\u00f3noma de M\u00e9xico. Disponible en\n[http://datosabiertos.unam.mx/IBUNAM:MEXU:1400209](http://datosabiertos.unam.mx/IBUNAM:MEXU:1400209)\nNichols, D. E., Johnson, M. W., & Nichols, C. D. (2017). Psychedelics as Medicines: An Emerging New Paradigm. Clinical Pharmacology and Therapeutics, 101(2), 209\u2013219.\n[https://doi.org/10.1002/cpt.557](https://doi.org/10.1002/cpt.557)\nNutt, D., Erritzoe, D., & Carhart-Harris, R. (2020). Psychedelic Psychiatry\u2019s Brave New World. Cell, 181(1), 24\u201328.\n[https://doi.org/10.1016/j.cell.2020.03.020](https://doi.org/10.1016/j.cell.2020.03.020)\nOrsolini, L., John-Smith, P. S., McQueen, D., Papanti, D., Corkery, J., & Schifano, F. (2017). Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism? Current Neuropharmacology, 15(5), 731.\n[https://doi.org/10.2174/1570159X15666161111114838](https://doi.org/10.2174/1570159X15666161111114838)\nOrsolini, L., Papanti, G. D., Francesconi, G., & Schifano, F. (2015). Mind Navigators of Chemicals\u2019 Experimenters? A Web-Based Description of E-Psychonauts. Https://Home.Liebertpub.Com/Cyber, 18(5), 296\u2013300.\n[https://doi.org/10.1089/CYBER.2014.0486](https://doi.org/10.1089/CYBER.2014.0486)\nOrtega, A., Blount, J. F., & Manchand, P. S. (1982). Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum (Labiatae). Journal of the Chemical Society, Perkin Transactions 1, (0), 2505\u20132508.\n[https://doi.org/10.1039/p19820002505](https://doi.org/10.1039/p19820002505)\nOrton, E., & Liu, R. (2014). Salvinorin A: A Mini Review of Physical and Chemical Properties Affecting Its Translation from Research to Clinical Applications in Humans. Translational Perioperative and Pain Medicine, 1(1), 9. /pmc/articles/PMC4208627/\nOtt, J. (1995). Ethnopharmacognosy and human pharmacology of Salvia divinorum and salvinorin A. Curare, 18(1), 103\u2013129.\nPeckys, D., & Hurd, Y. L. (2001). Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders. Brain research bulletin, 55(5), 619\u2013624.\n[https://doi.org/10.1016/s0361-9230(01)00525-1](https://doi.org/10.1016/s0361-9230(01)00525-1)\nPfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986). Psychotomimesis mediated by kappa opiate receptors. Science (New York, N.Y.), 233(4765), 774\u2013776.\n[https://doi.org/10.1126/science.3016896](https://doi.org/10.1126/science.3016896)\nPittaluga, A., Olivero, G., Di Prisco, S., Merega, E., Bisio, A., & Romussi, G. et al. (2013). Effects of the neoclerodane Hardwickiic acid on the presynaptic opioid receptors which modulate noradrenaline and dopamine release in mouse central nervous system. Neurochemistry International, 62(4), 354-359. doi: 10.1016/j.neuint.2013.01.016\nPrisinzano, T. E. (2005). Psychopharmacology of the hallucinogenic sage Salvia divinorum. Life Sciences, 78(5), 527\u2013531.\n[https://doi.org/10.1016/j.lfs.2005.09.008](https://doi.org/10.1016/j.lfs.2005.09.008)\nRagu Varman, D., Jayanthi, L. D., & Ramamoorthy, S. (2022). Kappa Opioid Receptor Mediated Differential Regulation of Serotonin and Dopamine Transporters in Mood and Substance Use Disorder. Handbook of experimental pharmacology, 271, 97\u2013112.\n[https://doi.org/10.1007/164_2021_499](https://doi.org/10.1007/164_2021_499)\nRoseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R. (2019). Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory. Journal of Psychopharmacology, 33(9), 1076\u20131087.\n[https://doi.org/10.1177/0269881119855974](https://doi.org/10.1177/0269881119855974)\nRoth, B. L., Lopez, E., Beischel, S., Westkaemper, R. B., & Evans, J. M. (2004). Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery. Pharmacology & therapeutics, 102(2), 99\u2013110.\n[https://doi.org/10.1016/j.pharmthera.2004.03.004](https://doi.org/10.1016/j.pharmthera.2004.03.004)\nRuiz Franco, J. C. 1967-. (2015). Albert Hofmann : vida y legado de un qui\u0301mico humanista. Editorial Liebre de Marzo. ISBN:978-84-92470-32-7\nSchmidt, M. D., Schmidt, M. S., Butelman, E. R., Harding, W. W., Tidgewell, K., Murry, D. J., Kreek, M. J., & Prisinzano, T. E. (2005). Pharmacokinetics of the plant-derived ??-opioid hallucinogen salvinorin A in nonhuman primates. Synapse, 58(3), 208\u2013210.\n[https://doi.org/10.1002/syn.20191](https://doi.org/10.1002/syn.20191)\nSchultes, R. E., Hofmann, A., & Ratsch, C. (2000). Plantas de los dioses: or\u00edgenes del uso de los alucin\u00f3genos (No. 581.6 S386p). Fondo de Cultura Econ\u00f3mica,.\nSecretar\u00eda de Salud. Ley General de Salud, art. 245-247. M\u00e9xico\nSerra, V., Fattore, L., Scherma, M., Collu, R., Spano, M. S., Fratta, W., & Fadda, P. (2015). Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat. Psychopharmacology, 232(1), 91\u2013100.\n[https://doi.org/10.1007/S00213-014-3641-Z](https://doi.org/10.1007/S00213-014-3641-Z)\nSgourev, S. V. (2021). Changing perspective: An \u201coptical\u201d approach to creativity. Poetics, 101581.\n[https://doi.org/10.1016/j.poetic.2021.101581](https://doi.org/10.1016/j.poetic.2021.101581)\nSiebert, D. J. (1994). Salvia divinorum and salvinorin A: new pharmacologic findings. Journal of Ethnopharmacology, 43(1), 53\u201356.\n[https://doi.org/10.1016/0378-8741(94)90116-3](https://doi.org/10.1016/0378-8741(94)90116-3)\nSiebert, D. J. (2004). Localization of Salvinorin A and Related Compounds in Glandular Trichomes of the Psychoactive Sage, Salvia divinorum. Annals of Botany, 93(6), 763.\n[https://doi.org/10.1093/AOB/MCH089](https://doi.org/10.1093/AOB/MCH089)\nSimonson, B., Morani, A. S., Ewald, A. W. M., Walker, L., Kumar, N., Simpson, D., Miller, J. H., Prisinzano, T. E., & Kivell, B. M. (2015). Pharmacology and anti-addiction effects of the novel \u03ba opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A. British Journal of Pharmacology, 172(2), 515\u2013531.\n[https://doi.org/10.1111/bph.12692](https://doi.org/10.1111/bph.12692)\nSoto-Restrepo, V., Taborda-Ocampo, G., & Garz\u00f3n-M\u00e9ndez, W. (2017). Salvinorina A: terpeno alucin\u00f3geno presente en Salvia divinorum Epling & J\u00e1tiva. Colombia Forense, 4(1).\n[https://doi.org/10.16925/cf.v4i1.2022](https://doi.org/10.16925/cf.v4i1.2022)\nSumnall, H. R., Measham, F., Brandt, S. D., & Cole, J. C. (2011). Salvia divinorum use and phenomenology: Results from an online survey. Journal of Psychopharmacology, 25(11), 1496\u20131507.\n[https://doi.org/10.1177/0269881110385596](https://doi.org/10.1177/0269881110385596)\nSun, J., Yang, X., Zhang, Y., Zhang, W., Lu, J., Hu, Q., \u2026 Chen, C. (2019). Salvinorin A attenuates early brain injury through PI3K/Akt pathway after subarachnoid hemorrhage in rat. Brain Research, 1719, 64\u201370.\n[https://doi.org/10.1016/j.brainres.2019.05.026](https://doi.org/10.1016/j.brainres.2019.05.026)\nSun, J., Yang, X., Zhang, Y., Zhang, W., Lu, J., Hu, Q., Liu, R., Zhou, C., & Chen, C. (2019). Salvinorin A attenuates early brain injury through PI3K/Akt pathway after subarachnoid hemorrhage in rat. Brain Research, 1719, 64\u201370.\n[https://doi.org/10.1016/j.brainres.2019.05.026](https://doi.org/10.1016/j.brainres.2019.05.026)\nTaylor, G. T., & Manzella, F. (2016). Kappa Opioids, Salvinorin A and Major Depressive Disorder. Current neuropharmacology, 14(2), 165\u2013176.\n[https://doi.org/10.2174/1570159x13666150727220944](https://doi.org/10.2174/1570159x13666150727220944)\nTejeda, H. A., Hanks, A. N., Scott, L., Mejias-Aponte, C., Hughes, Z. A., & O\u2019donnell, P. (2015). Prefrontal Cortical Kappa Opioid Receptors Attenuate Responses to Amygdala Inputs. Neuropsychopharmacology 2015 40:13, 40(13), 2856\u20132864.\n[https://doi.org/10.1038/npp.2015.138](https://doi.org/10.1038/npp.2015.138)\nTeksin, Z. S., Lee, I. J., Nemieboka, N. N. et al., 2009. Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen. Eur J PharmBiopharm, 72, 471-477.\nThomas, G., Lucas, P., Capler, N., Tupper, K., & Martin, G. (2013). Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada. Current Drug Abuse Reviews, 6(1), 30\u201342.\n[https://doi.org/10.2174/15733998113099990003](https://doi.org/10.2174/15733998113099990003)\nTimmermann, C. S. (2014). Neurosciences and psycotherapeutic applications in the psychedelic research renaissaince. In Revista Chilena de Neuro-Psiquiatria (Vol. 52, Issue 2, pp. 93\u2013102). Sociedad de Neurologia Psiquiatria y Neurocirugia.\n[https://doi.org/10.4067/s0717-92272014000200005](https://doi.org/10.4067/s0717-92272014000200005)\nTimmermann, C., Spriggs, M. J., Kaelen, M., Leech, R., Nutt, D. J., Moran, R. J., Carhart-Harris, R. L., & Muthukumaraswamy, S. D. (2018). LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm. Neuropharmacology, 142, 251\u2013262.\n[https://doi.org/10.1016/j.neuropharm.2017.10.039](https://doi.org/10.1016/j.neuropharm.2017.10.039)\nTlacomulco-Flores, L., D\u00e9ciga-Campos, M., Gonz\u00e1lez-Trujano, M., Carballo-Villalobos, A., & Pellicer, F. (2020). Antinociceptive effects of Salvia divinorum and bioactive salvinorins in experimental pain models in mice. Journal Of Ethnopharmacology, 248, 112276. doi: 10.1016/j.jep.2019.112276\nTsujikawa, K., Kuwayama, K., Miyaguchi, H., Kanamori, T., Iwata, Y. T., Yoshida, T., & Inoue, H. (2008). Determination of salvinorin A and salvinorin B in Salvia divinorum-related products circulated in Japan. Forensic Science International, 180(2\u20133), 105\u2013109.\n[https://doi.org/10.1016/j.forsciint.2008.07.008](https://doi.org/10.1016/j.forsciint.2008.07.008)\nTullis, P. (2021). How ecstasy and psilocybin are shaking up psychiatry. Nature, 589(7843), 506\u2013509.\n[https://doi.org/10.1038/d41586-021-00187-9](https://doi.org/10.1038/d41586-021-00187-9)\nTurnes, J. de M., Araya, E. I., Barroso, A. R., Baggio, D. F., Koren, L. de O., Zanoveli, J. M., & Chichorro, J. G. (2022). Blockade of kappa opioid receptors reduces mechanical hyperalgesia and anxiety-like behavior in a rat model of trigeminal neuropathic pain. Behavioural Brain Research, 417.\n[https://doi.org/10.1016/J.BBR.2021.113595](https://doi.org/10.1016/J.BBR.2021.113595)\nTurton, S., Nutt, D. J., & Carhart-Harris, R. L. (2014). A Qualitative Report on the Subjective Experience of Intravenous Psilocybin Administered in an fMRI Environment. Current Drug Abuse Reviews, 7(2), 117\u2013127.\n[https://doi.org/10.2174/1874473708666150107120930](https://doi.org/10.2174/1874473708666150107120930)\nVald\u00e9s, L. J. (1994). Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin) A. Journal of Psychoactive Drugs, 26(3), 277\u2013283.\n[https://doi.org/10.1080/02791072.1994.10472441](https://doi.org/10.1080/02791072.1994.10472441)\nVald\u00e9s, L. J., D\u00edaz, J., & Paul, A. G. (1983). Ethnopharmacology of ska Mar\u00eda Pastora (Salvia divinorum, Epling and J\u00e1tiva-M.). Journal of Ethnopharmacology, 7(3), 287\u2013312.\n[https://doi.org/10.1016/0378-8741(83)90004-1](https://doi.org/10.1016/0378-8741(83)90004-1)\nWeitlaner, R. J. (1950). Curaciones mazatecas. Anales Del Instituto Nacional de Antropolog\u00eda e Historia, 279\u2013285.\n[https://revistas.inah.gob.mx/index.php/anales/article/view/7136](https://revistas.inah.gob.mx/index.php/anales/article/view/7136)\nWhite, K. L., & Roth, B. L. (2012). Psychotomimetic effects of kappa opioid receptor agonists. In Biological Psychiatry (Vol. 72, Issue 10, pp. 797\u2013798). Biol Psychiatry.\n[https://doi.org/10.1016/j.biopsych.2012.08.014](https://doi.org/10.1016/j.biopsych.2012.08.014)\nYan, F., Mosier, P. D., Westkaemper, R. B., Stewart, J., Zjawiony, J. K., Vortherms, T. A., Sheffler, D. J., & Roth, B. L. (2005). Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptors. Biochemistry, 44, 8643\u20138651.\n[https://doi.org/10.1021/bi050490d](https://doi.org/10.1021/bi050490d)\nDescargas\nPublicado\nC\u00f3mo citar\nN\u00famero\nSecci\u00f3n\nLicencia\nDerechos de autor 2022 Revista ConCiencia EPG\nEsta obra est\u00e1 bajo una licencia internacional\n[Creative Commons Atribuci\u00f3n-NoComercial 4.0](https://creativecommons.org/licenses/by-nc/4.0/).", "language": null, "image": null, "pagetype": null, "links": ["#pkp_content_main", "#siteNav", "#pkp_content_footer", "\t\t\t\t\t\thttp://revistaconcienciaepg.edu.pe/ojs/index.php/55551/index\n\t\t\t\t\t", null, "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/revista", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/ISSN", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Tematicaalcance", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/frecuenciadepublicacion", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/EQUIPOEDITORIAL", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/issue/current", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/issue/archive", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Preprint", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/about/submissions", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/normasautor", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/codigodeetica", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/politicaspublicacion", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/revisionporpares", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/sobrelosnespeciales", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/INDEXACIONLOG", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/revisores", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/RevisoresVol8Num2", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/revedesp81", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/vol81", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/revisoresv7n2", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/edicionespecialrevisores", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/revisores7-1", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/resisoers6-2", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/revisiresnumero6vol1", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/autoresporvolumen", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/AutoresVol8Num2", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/autores81", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/v81edesp", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/autoresv7n2", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/EdicionEspecial", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/volumen7Numero1", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Volumen6Numero2", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Volumen6Numero1", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Volumen5Numero2", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Volumen5Numero1", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Volumen4Numero2", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Volumen4Numero1", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Volumen3Numereo2", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Volumen3Numero1", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Volumen2Numero2", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Volumen2Numero1", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Volumen1Numero2", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/Volumen1Numero1", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/search/search", "#", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/user/register", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/login", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/search/search", "#", null, "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/index", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/issue/archive", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/issue/view/14", "https://doi.org/10.32654/ConCienciaEPG/Eds.especial-9", "https://doi.org/10.1007/S00213-011-2470-6", "https://doi.org/10.1177/0269881115570081", "https://doi.org/10.1038/S41386-018-0294-3", "https://doi.org/10.1016/j.drugalcdep.2010.05.003", "https://doi.org/10.1177/0269881116678781", "https://doi.org/10.1371/journal.pone.0229067", "https://doi.org/10.1111/j.1476-5381.2009.00230.x", "https://doi.org/10.3389/fphar.2015.00190", "https://doi.org/10.1124/jpet.106.112417", "https://doi.org/10.1124/jpet.108.145342", "https://doi.org/10.1073/pnas.1119598109", "https://doi.org/10.1038/s41598-017-13282-7", "https://doi.org/10.1177/0269881118754710", "https://doi.org/10.1017/S1461145713001405", "https://doi.org/10.1371/journal.pone.0058701", "https://doi.org/10.1038/S41386-021-01146-8", "https://doi.org/10.1124/pr.110.003244", "https://doi.org/10.1016/j.drugalcdep.2012.08.008", "https://doi.org/10.3390/ijms17111953", "https://www.dea.gov/drug-information/drug-scheduling", "https://doi.org/10.1146/ANNUREV.PA.17.040177.003243", "https://doi.org/CDAR-EPUB-20130429-4", "https://doi.org/10.1016/j.tsc.2021.100826", "https://doi.org/10.1590/1414-431x20176714", "https://doi.org/10.1016/j.expneurol.2019.113045", "https://doi.org/10.1007/978-3-642-73223-2_9", "https://www.emcdda.europa.eu/publications/drug-profiles/salvia_en", "https://doi.org/10.1046/j.1460-9568.2001.02009.x", "https://doi.org/10.1093/NC/NIAA004", "http://datosabiertos.unam.mx/IBUNAM:MEXU:87556", "https://doi.org/10.1016/j.drugalcdep.2006.04.001", "https://doi.org/10.3406/intel.2017.1836", "https://doi.org/10.3389/FPSYG.2021.645246/BIBTEX", "https://doi.org/10.1001/archgenpsychiatry.2010.116", "https://doi.org/10.1055/s-2007-981566", "https://doi.org/10.1097/00004714-200112000-00025", "https://doi.org/10.1097/FBP.0b013e3283586189", "https://doi.org/10.1016/j.forsciint.2015.01.038", "https://doi.org/10.1159/000136803", "https://doi.org/10.1007/BF02160424", "https://doi.org/10.1002/hlca.19590420518", "https://doi.org/10.2307/1384454", "https://doi.org/10.1016/j.neuroimage.2008.03.003", "https://www.insp.mx/avisos/5128-dia-uso-nocivo-alcohol.html", "https://doi.org/10.1111/j.1556-4029.2009.00999.x", "https://doi.org/10.1186/S13041-020-00669-3/FIGURES/3", "https://doi.org/10.1177/0269881114568039", "https://doi.org/10.1016/j.drugalcdep.2010.11.005", "https://doi.org/10.1177/0269881108093587", "https://doi.org/10.1016/BS.IRN.2017.08.001", "https://doi.org/10.1016/j.neuropharm.2014.07.016", "https://doi.org/10.1016/J.BRAINRES.2009.09.074", "https://doi.org/10.1016/j.drugalcdep.2009.11.010", "https://doi.org/10.1111/J.1399-3011.1986.TB01824.X", "http://datosabiertos.unam.mx/IBUNAM:MEXU:1051410", "https://doi.org/10.1007/s00213-012-2912-9", "https://doi.org/10.1139/cjr31-097", "https://doi.org/10.1093/ijnp/pyw016", "https://doi.org/10.1136/bmj.1.5588.380", "https://doi.org/10.1002/rcm.2288", "https://doi.org/10.7202/1027832AR", "https://doi.org/10.1002/syn.22042", "https://doi.org/10.1177/0269881110378371", "https://doi.org/10.1016/j.pbb.2009.09.002", "https://doi.org/10.3389/FPHAR.2019.00407/BIBTEX", "https://doi.org/10.1186/S12954-020-00399-8/TABLES/2", "https://doi.org/10.1021/np0205699", "https://doi.org/10.3389/FPSYT.2020.546796/BIBTEX", "http://datosabiertos.unam.mx/IBUNAM:MEXU:1400209", "https://doi.org/10.1002/cpt.557", "https://doi.org/10.1016/j.cell.2020.03.020", "https://doi.org/10.2174/1570159X15666161111114838", "https://doi.org/10.1089/CYBER.2014.0486", "https://doi.org/10.1039/p19820002505", "https://doi.org/10.1016/s0361-9230(01)00525-1", "https://doi.org/10.1126/science.3016896", "https://doi.org/10.1016/j.lfs.2005.09.008", "https://doi.org/10.1007/164_2021_499", "https://doi.org/10.1177/0269881119855974", "https://doi.org/10.1016/j.pharmthera.2004.03.004", "https://doi.org/10.1002/syn.20191", "https://doi.org/10.1007/S00213-014-3641-Z", "https://doi.org/10.1016/j.poetic.2021.101581", "https://doi.org/10.1016/0378-8741(94)90116-3", "https://doi.org/10.1093/AOB/MCH089", "https://doi.org/10.1111/bph.12692", "https://doi.org/10.16925/cf.v4i1.2022", "https://doi.org/10.1177/0269881110385596", "https://doi.org/10.1016/j.brainres.2019.05.026", "https://doi.org/10.1016/j.brainres.2019.05.026", "https://doi.org/10.2174/1570159x13666150727220944", "https://doi.org/10.1038/npp.2015.138", "https://doi.org/10.2174/15733998113099990003", "https://doi.org/10.4067/s0717-92272014000200005", "https://doi.org/10.1016/j.neuropharm.2017.10.039", "https://doi.org/10.1016/j.forsciint.2008.07.008", "https://doi.org/10.1038/d41586-021-00187-9", "https://doi.org/10.1016/J.BBR.2021.113595", "https://doi.org/10.2174/1874473708666150107120930", "https://doi.org/10.1080/02791072.1994.10472441", "https://doi.org/10.1016/0378-8741(83)90004-1", "https://revistas.inah.gob.mx/index.php/anales/article/view/7136", "https://doi.org/10.1016/j.biopsych.2012.08.014", "https://doi.org/10.1021/bi050490d", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/issue/view/14", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/article/view/218/144", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/citationstylelanguage/get/acm-sig-proceedings?submissionId=218&publicationId=219", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/citationstylelanguage/get/acs-nano?submissionId=218&publicationId=219", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/citationstylelanguage/get/apa?submissionId=218&publicationId=219", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/citationstylelanguage/get/associacao-brasileira-de-normas-tecnicas?submissionId=218&publicationId=219", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/citationstylelanguage/get/chicago-author-date?submissionId=218&publicationId=219", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/citationstylelanguage/get/harvard-cite-them-right?submissionId=218&publicationId=219", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/citationstylelanguage/get/ieee?submissionId=218&publicationId=219", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/citationstylelanguage/get/modern-language-association?submissionId=218&publicationId=219", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/citationstylelanguage/get/turabian-fullnote-bibliography?submissionId=218&publicationId=219", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/citationstylelanguage/get/vancouver?submissionId=218&publicationId=219", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/citationstylelanguage/download/ris?submissionId=218&publicationId=219", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/citationstylelanguage/download/bibtex?submissionId=218&publicationId=219", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/issue/view/14", "https://creativecommons.org/licenses/by-nc/4.0/", "https://creativecommons.org/licenses/by-nc/4.0/", null, null, null, null, null, null, "https://plu.mx/plum/a/?doi=10.32654/ConCienciaEPG/Eds.especial-9", "https://scholar.google.com/scholar?q=10.32654/ConCienciaEPG/Eds.especial-9", "http://europepmc.org/search?scope=fulltext&query=(REF:10.32654/ConCienciaEPG/Eds.especial-9)", "https://doi.org/10.32654/ConCienciaEPG", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/about/submissions", "https://journalseeker.researchbib.com/view/issn/2523-6687", "https://latinoamericanarevistas.org/revista-conciencia-epg/", "https://www.sciencegate.app/source/325528", "https://europub.co.uk/journals/29148", "https://sdbindex.com/Sourceid/00000376", "https://livre2.cnen.gov.br/ConsultaPorPalavras.asp", "http://olddrji.lbp.world/Publisher/MyAccount.aspx?uname=2523-6687%20", "https://doaj.org/toc/2523-6687?source=%7B%22query%22%3A%7B%22bool%22%3A%7B%22must%22%3A%5B%7B%22terms%22%3A%7B%22index.issn.exact%22%3A%5B%222517-9896%22%2C%222523-6687%22%5D%7D%7D%5D%7D%7D%2C%22size%22%3A100%2C%22sort%22%3A%5B%7B%22created_date%22%3A%7B%22order%22%3A%22desc%22%7D%7D%5D%2C%22_source%22%3A%7B%7D%2C%22track_total_hits%22%3Atrue%7D", "https://latinrev.flacso.org.ar/revistas/conciencia-epg", "ttps://clase.dgb.unam.mx/F/E8R3PGYGDFPXIQ2IAJDKUX8LA7TTQX11CF9DP1DCKMAIF5ET5F-15366?func=find-acc&acc_sequence=001011181", "https://biblat.unam.mx/es/revista/conciencia-epg", "https://dialnet.unirioja.es/servlet/revista?codigo=26688", "https://kanalregister.hkdir.no/publiseringskanaler/erihplus/periodical/info.action?id=498398", "https://miar.ub.edu/issn/2523-6687", "https://alicia.concytec.gob.pe/vufind/Search/Results?lookfor=Revista+ConCiencia+EPG&type=AllFields&filter%5B%5D=reponame_str%3A%22Revista+UNE+-+ConCiencia+EPG%22", "http://www.citrevistas.cl/actualidad/b2b_g10.htm", "https://www.latindex.org/latindex/ficha/23398", "ttps://clase.dgb.unam.mx/F/E8R3PGYGDFPXIQ2IAJDKUX8LA7TTQX11CF9DP1DCKMAIF5ET5F-15366?func=find-acc&acc_sequence=001011181", "https://biblat.unam.mx/es/revista/conciencia-epg", "https://dialnet.unirioja.es/servlet/revista?codigo=26688", "https://kanalregister.hkdir.no/publiseringskanaler/erihplus/periodical/info.action?id=498398", "https://miar.ub.edu/issn/2523-6687", "https://researcher.life/journal/conciencia-epg/39832?openScopeMatch=true", "http://aura.amelica.org/detalle-revista.html?cveRevista=1127", "https://search.crossref.org/", "https://portal.issn.org/api/search?search[]=MUST=allissnbis=%222517-9896%22&search_id=25580847", "https://portal.issn.org/resource/ISSN/2523-6687#", "https://www.facebook.com/people/Revista-ConCiencia-EPG/100063680944458/", "https://twitter.com/EpgRevista", "https://www.linkedin.com/in/revista-conciencia-epg-339638245/?original_referer=http%3A%2F%2Frevistaconcienciaepg.edu.pe%2F", "https://une-pe.academia.edu/RevistaConCienciaEPG", "https://scholar.google.es/citations?user=zFX6dp8AAAAJ&hl=es", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/gateway/plugin/WebFeedGatewayPlugin/atom", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/gateway/plugin/WebFeedGatewayPlugin/rss2", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/gateway/plugin/WebFeedGatewayPlugin/rss", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/information/readers", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/information/authors", "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/information/librarians", "http://pkp.sfu.ca/ojs/", null, "http://revistaconcienciaepg.edu.pe/ojs/index.php/55551/about/aboutThisPublishingSystem"]}